trifluoperazine has been researched along with Angiogenesis, Pathologic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, J | 1 |
| Huang, Z | 1 |
| Chen, X | 1 |
| Luo, R | 1 |
| Cai, H | 1 |
| Wang, H | 1 |
| Zhang, H | 1 |
| Sun, T | 1 |
| Zhang, Y | 1 |
1 other study available for trifluoperazine and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Trifluoperazine Activates FOXO1-Related Signals to Inhibit Tumor Growth in Hepatocellular Carcinoma.
Topics: Apoptosis; Carcinoma, Hepatocellular; Cell Cycle Checkpoints; Cell Line, Tumor; Forkhead Box Protein | 2017 |